biosimilars

Roche readies new drugs in two-year window before copycats hit
Yahoo/Reuters
Thu, 07/23/15 - 12:06 pm
Roche
biosimilars
Herceptin
Rituxan
Biosimilars will cut top 10 vulnerable biologics almost in half by 2020: Morningstar
Fierce Pharma Marketing
Wed, 07/22/15 - 09:36 pm
biosimilars
AbbVie
Roche
Amgen
Rituxan
Herceptin
Avastin
Neupogen
Neulasta
Epogen
Humira
Perjeta
Gazyva
Novartis blocked from selling Neupogen copycat until Sept. 2
Yahoo/Reuters
Tue, 07/21/15 - 12:47 pm
Novartis
biosimilars
Neupogen
Zarxio
Sandoz
Amgen
J&J prepares to defend Remicade market share
Medical Marketing and Media
Tue, 07/14/15 - 10:34 pm
JNJ
Remicade
biosimilars
Alex Gorsky
Merck and Samsung's Humira biosimilar comes through in Phase III
Fierce Biotech
Wed, 07/8/15 - 09:23 am
Merck
Humira
biosimilars
SB5
Samsung Bioepis
AbbVie
rheumatoid arthritis
Big deal for biosims? Major French hospital group opts for Hospira's Remicade copy
BioPharma Dive
Mon, 07/6/15 - 12:07 pm
biosimilars
France
Hospira
Remicade
Pharmacy groups urge consistent naming of biosimilars
Medical Marketing and Media
Wed, 07/1/15 - 10:50 pm
biosimilars
drug names
Bad news for AstraZeneca: FDA lays out roadmap for would-be Symbicort copycats
Fierce Pharma
Wed, 07/1/15 - 04:10 pm
FDA
AstraZeneca
Symbicort
biosimilars
AbbVie has room to cut marketing spend if Humira biosims start hurting: analysts
Fierce Pharma Marketing
Wed, 07/1/15 - 12:09 pm
AbbVie
Humira
biosimilars
Samsung and Biogen plot an IPO for their biosimilars JV
Fierce Biotech
Tue, 06/30/15 - 11:32 am
Samsung
Biogen
IPOs
biosimilars
Samsung Bioepis
Biosimilar of Novartis' eye drug Lucentis launched in India
Fierce Pharma
Fri, 06/19/15 - 05:13 pm
Novartis
India
Lucentis
biosimilars
Pfizer Buys Your Biosimilar Partner? How Pfenex’ Heartburn Was Quickly Relieved
Informabi
Thu, 06/18/15 - 11:07 am
BIO2015
biosimilars
Pfenex
Pfizer
Hospira
Lucentis
PF582
Bad news for AbbVie: Humira copies expected to rack up biggest biosim sales
Fierce Pharma
Tue, 06/16/15 - 12:15 pm
AbbVie
Humira
biosimilars
Pharmacyclics
What’s in a Name? Contentious Fight Over Biosimilars Coming to a Head
WSJ Pharmalot
Fri, 06/12/15 - 10:46 pm
biosimilars
FDA
generics
Biogen's Biosimilars Program Leaps Forward
Investopedia
Fri, 06/12/15 - 09:28 am
Biogen
biosimilars
Biosim war heats up as Merck's Remicade & Enbrel biosimilars bag major wins in RA
BioPharma Dive
Wed, 06/10/15 - 11:10 am
Merck
Remicade
Enbrel
biosimilars
rheumatoid arthritis
Drug switch study bolsters case for copies of biotech medicine
Yahoo/Reuters
Wed, 06/10/15 - 09:10 am
biosimilars
Merck
JNJ
Remicade
This Key Amgen Drug Is Setting a Precedent
Investopedia
Tue, 06/9/15 - 09:55 am
Amgen
Neupogen
Zarxio
Novartis
biosimilars
Return of the Scarlet Letter? AbbVie Petitions FDA to Require Biosimilar Labeling to Include Disclaimers and a Description of Data Differences
Fierce Pharma Marketing
Wed, 06/3/15 - 07:40 pm
FDA
biosimilars
AbbVie
Novartis tries to get U.S. ban lifted on sale of Neupogen copycat
Yahoo/Reuters
Wed, 06/3/15 - 07:37 pm
Novartis
Neupogen
biosimilars
Zarxio
Amgen
Sandoz

Pages